These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16422212)

  • 1. [Bronchodilators reduce air-trapping in COPD patients].
    Welte T
    Med Klin (Munich); 2005 Oct; 100 Suppl 1():9-11. PubMed ID: 16422212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of COPD. Reducing air trapping in the lung--improving physical capacity].
    MMW Fortschr Med; 2005 May; 147(19):54-5. PubMed ID: 15940941
    [No Abstract]   [Full Text] [Related]  

  • 4. [Importance of air-trapping in patients with COPD. Pathophysiological principle].
    Voshaar TH
    Med Klin (Munich); 2005 Oct; 100 Suppl 1():5-8. PubMed ID: 16422211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
    O'Donnell DE; Hamilton AL; Webb KA
    J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tiotropium, a long-acting bronchodilating agent for the treatment of COPD].
    Schuurbiers OC; Schermer TR; Dekhuijzen PN; van Weel C
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1227-32. PubMed ID: 16796173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
    Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
    Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Air trapping in COPD].
    Mitfessel H
    Krankenpfl J; 2005; 43(4-6):117. PubMed ID: 16171063
    [No Abstract]   [Full Text] [Related]  

  • 10. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
    Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K
    Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tiotropium as new quality medication in the COPD management].
    Lubiński W; Płusa T
    Pol Merkur Lekarski; 2006 Jan; 20(115):5-7. PubMed ID: 16617725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of aerosol oxitropium bromide and fenoterol on maximal exercise capacity in chronic obstructive pulmonary disease and their correlation with air flow during exercise and with parameters of maximal exercise].
    Suruda T; Nakamura H; Kobayashi H; Uetani K; Nishio M; Higashimoto Y; Funasako M; Ohata M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Sep; 31(9):1089-95. PubMed ID: 8255017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
    Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
    Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of dynamic hyperinflation parameters and exercise capacity at maximal exercise in patients with COPD].
    Ulubay G; Görek A; Savaş S; Oner Eyüboğlu F
    Tuberk Toraks; 2005; 53(4):340-6. PubMed ID: 16456732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of replacing oxitropium with tiotropium on pulmonary function in patients with COPD: a randomized study.
    Incorvaia C; Riario-Sforza GG; Pravettoni C; Dugnani N; Paterniti F; Pessina L; Fumagalli M
    Respir Med; 2007 Mar; 101(3):476-80. PubMed ID: 16919926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expiratory flow-limitation and heliox breathing in resting and exercising COPD patients.
    D'Angelo E; Santus P; Civitillo MF; Centanni S; Pecchiari M
    Respir Physiol Neurobiol; 2009 Dec; 169(3):291-6. PubMed ID: 19770071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
    Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.